The 17 linked references in paper N. Kashirskaya Yu., E. Amelina L., S. Krasovskiy A., Н. Каширская Ю., Е. Амелина Л., С. Красовский А. (2017) “Ранняя эрадикация синегнойной инфекции при муковисцидозе // Early eradication of Pseudomonas aeruginosa infection in cystic fibrosis” / spz:neicon:pulmonology:y:2017:i:1:p:81-86

  1. Красовский С.А., Амелина Е.Л., Кондратьева Е.И. и др. Респираторная инфекция нижних дыхательных путей у больных муковисцидозом в Российской Федерации по данным Национального регистра (2014). Пульмонология. 2016; 28 (4): 421–435. DOI: 10.18093/ 0869-0189-2016-26-4-421-435.
  2. Flume P.A., VanDevanter D.R. Clinical applications of pulmonary delivery of antibiotics.Adv. Drug Deliv. Rev.2015; 85: 1–6. DOI: 10.1016/j.addr.2014.10.009.
  3. Smyth A.R., Bell S.C., Bojcin S. et al. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. J. Cyst. Fibros. 2014; 13 (Suppl. 1): S23–S42. DOI: 10.1016/j.jcf.2014.03.010.
  4. Høiby N., Frederiksen B., Pressler T. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros.2005; 4 (Suppl. 2): 49–54. DOI: 10.1016/j.jcf.2005.05.018.
  5. Taccetti G., Bianchini E., Cariani L. et al. Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomized multicentre study comparing two different protocols. Thorax. 2012; 67 (10): 853–859. DOI: 10.1136/thoraxjnl-2011-200832.
  6. Lee T.W. Eradication of early Pseudomonas infection in cystic fibrosis. Chron. Respir. Dis.2009; 6 (2): 99–107. DOI: 10.1177/1479972309104661.
  7. Emerson J., Rosenfeld M., McNamara S. et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr. Pulmonol.2002; 34 (2): 91–100. DOI: 10.1002/ppul.10127.
  8. Langton-Hewer S.C., Smyth A.R. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst. Rev.2014; (11): CD004197. DOI: 10.1002/14651858.CD004197.pub4.
  9. Munck A., Bonacorsi S., Mariani-Kurkdjian P. et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization.Pediatr. Pulmonol.2001; 32 (4): 288–292. DOI: 10.1002/ppul.1121.
  10. Ratjen F., Munck A., Kho P., Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 2010; 65 (4): 286–291. DOI: 10.1136/thx.2009.121657.
  11. Kenny S.L., Shaw T.D., Downey D.G. et al. Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis. BMJ Open Respir. Res.2014; 1: e000021. DOI: 10.1136/bmjresp2014-000021.
  12. Brodt A.M., Stovold E., Zhang L. Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review. Eur. Respir. J.2014; 44 (2): 382–393. DOI: 10.1183/09031936.00018414.
  13. Rosenfeld M., Emerson J., McNamara S. et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J. Cyst. Fibros.2012; 11 (5): 446–453. DOI: 10.1016/j.jcf.2012.04.003.
  14. Proesmans M., Vermeulen F., Boulanger L. et al. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.J. Cyst. Fibros.2013; 12 (1): 29–34. DOI: 10.1016/j.jcf.2012.06.001.
  15. Geller D.E., Flume P.A., Staab D. et al. Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas aeruginosa. Am. J. Respir. Crit. Care Med.2011; 183 (11): 1510–1516. DOI: 10.1164/rccm. 201008-1293OC.
  16. Stanojevic S., Waters V., Mathew J.L. et al. Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis.J. Cyst. Fibros.2014; 13 (2): 172–178. DOI: 10.1016/j.jcf.2013.09.002.
  17. Cohen-Cymberknoh M., Gilead N., Gartner S. et al. Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis. J. Cyst. Fibros.2016; 15 (6): 776–782. DOI: 10.1016/j.jcf.2016.04.006. Поступила 16.02.17